Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)

Triumph Group Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	102,688	92,857	46,237	45,083	62,730
Short-Term Investments	-	45,357	53,712	60,041	44,695	32,592
Trading Asset Securities	-	113,183	44,332	45,022	36,771	310
Cash & Short-Term Investments	261,227	261,227	190,901	151,300	126,548	95,632
Cash Growth	36.84%	36.84%	26.17%	19.56%	32.33%	-12.58%
Accounts Receivable	-	130,610	112,602	114,568	105,035	90,979
Other Receivables	-	2,964	6,188	4,136	3,509	7,366
Receivables	-	134,058	119,440	119,117	110,243	98,905
Inventory	-	107,593	102,949	109,683	92,392	93,618
Prepaid Expenses	-	3,750	4,135	3,718	2,862	2,787
Other Current Assets	-	19,617	17,325	15,015	16,601	13,479
Total Current Assets	-	526,245	434,750	398,833	348,646	304,421
Property, Plant & Equipment	-	112,703	113,001	113,537	111,689	111,715
Long-Term Investments	-	46,977	64,412	54,517	49,592	64,824
Goodwill	-	89,394	85,690	83,580	65,913	62,876
Other Intangible Assets	-	90,205	87,330	93,268	61,918	56,607
Long-Term Accounts Receivable	-	-	-	108.3	193.7	305.5
Long-Term Deferred Tax Assets	-	44,076	41,037	35,189	28,496	35,564
Other Long-Term Assets	-	11,378	28,769	28,396	31,623	40,348
Total Assets	-	921,006	854,997	807,436	698,078	676,667
Accounts Payable	-	61,843	56,533	56,815	44,898	39,737
Accrued Expenses	-	18,856	16,889	15,127	14,833	11,972
Short-Term Debt	-	18,671	28,444	59,583	4,685	24,449
Current Portion of Long-Term Debt	-	-	-	2,396	2,323	4,239
Current Portion of Leases	-	1,368	1,257	1,281	1,078	1,017
Current Income Taxes Payable	-	7,332	4,117	3,087	1,756	1,791
Current Unearned Revenue	-	1,344	1,265	1,567	1,930	2,143
Other Current Liabilities	-	72,528	61,339	59,214	100,582	76,110
Total Current Liabilities	-	181,942	169,844	199,070	172,085	161,456
Long-Term Debt	-	25.2	13.3	-	2,299	6,547
Long-Term Leases	-	3,557	3,023	5,599	2,518	2,434
Long-Term Unearned Revenue	-	3,767	4,887	5,699	6,188	7,186
Long-Term Deferred Tax Liabilities	-	1,924	1,719	316.9	318.6	445.1
Other Long-Term Liabilities	-	395.2	253.7	334.6	575.4	914.6
Total Liabilities	-	196,146	183,737	214,281	187,417	181,869
Common Stock	-	2,399	2,399	2,399	2,399	2,399
Additional Paid-In Capital	-	11,874	11,874	11,874	11,874	11,874
Retained Earnings	-	614,525	537,452	472,009	412,363	401,887
Comprehensive Income & Other	-	93,382	84,942	73,671	53,476	48,467
Total Common Equity	722,180	722,180	636,668	559,954	480,112	464,628
Minority Interest	-	2,679	34,592	33,201	30,549	30,171
Shareholders' Equity	724,860	724,860	671,259	593,155	510,661	494,798
Total Liabilities & Equity	-	921,006	854,997	807,436	698,078	676,667
Total Debt	23,622	23,622	32,737	68,859	12,903	38,686
Net Cash (Debt)	237,605	237,605	158,164	82,441	113,645	56,946
Net Cash Growth	50.23%	50.23%	91.85%	-27.46%	99.57%	116.94%
Net Cash Per Share	99.08	99.03	65.92	34.36	47.37	23.73
Filing Date Shares Outstanding	2,399	2,399	2,399	2,399	2,399	2,399
Total Common Shares Outstanding	2,399	2,399	2,399	2,399	2,399	2,399
Working Capital	-	344,303	264,906	199,763	176,562	142,965
Book Value Per Share	300.99	300.99	265.35	233.38	200.10	193.65
Tangible Book Value	542,581	542,581	463,648	383,105	352,282	345,145
Tangible Book Value Per Share	226.14	226.14	193.24	159.67	146.82	143.85
Land	-	7,856	8,173	6,676	6,448	4,426
Buildings	-	65,668	63,610	61,395	57,836	57,091
Machinery	-	152,025	146,265	139,645	132,031	124,281
Construction In Progress	-	12,343	11,077	9,634	7,975	9,365

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.